Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 28,647

Sort by:

Lipopolysaccharide (Endotoxin) - Drugs in Development, 2021

US$ 3,000.00

Lipopolysaccharide (Endotoxin) - Drugs in Development, 2021 SUMMARY Lipopolysaccharide (Endotoxin) - Drugs in Development, 2021 provides in depth analysis on Lipopolysaccharide (Endotoxin) targeted pi...

April 2021 45 pages

Liposarcoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Liposarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Liposarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Liposarcoma pipeline landscape. The report provides comprehe...

April 2021 80 pages

Liver Cancer (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Liver Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Liver Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Liver Cancer pipeline landscape. The report provides compr...

April 2021 325 pages

Liver Fibrosis (Gastrointestinal) - Drugs in Development, 2021

US$ 2,500.00

Liver Fibrosis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Liver Fibrosis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Liver Fibrosis pipeline landscape. The...

April 2021 210 pages

Liver X Receptor (LXR) - Drugs in Development, 2021

US$ 3,000.00

Liver X Receptor (LXR) - Drugs in Development, 2021 SUMMARY Liver X Receptor (LXR) - Drugs in Development, 2021 provides in depth analysis on Liver X Receptor (LXR) targeted pipeline therapeutics. The...

April 2021 30 pages

Local Anesthetic Effect (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Local Anesthetic Effect (Central Nervous System) - Drugs in Development, 2021 SUMMARY Local Anesthetic Effect (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Local An...

April 2021 35 pages

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b (CDw32 or Fc Gamma RII-b or CD32 or FCGR2B) - Drugs in Development, 2021

US$ 3,000.00

Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b (CDw32 or Fc Gamma RII-b or CD32 or FCGR2B) - Drugs in Development, 2021 SUMMARY Low Affinity Immunoglobulin Gamma Fc Region Receptor II-b (CD...

April 2021 35 pages

Low Density Lipoprotein Receptor Related Protein 6 (LRP6) - Drugs in Development, 2021

US$ 3,000.00

Low Density Lipoprotein Receptor Related Protein 6 (LRP6) - Drugs in Development, 2021 SUMMARY Low Density Lipoprotein Receptor Related Protein 6 (LRP6) - Drugs in Development, 2021 provides in depth...

April 2021 30 pages

Low-Grade Glioma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Low-Grade Glioma (Oncology) - Drugs in Development, 2021 SUMMARY Low-Grade Glioma (Oncology) - Drugs in Development, 2021 provides an overview of the Low-Grade Glioma pipeline landscape. The report pr...

April 2021 50 pages

Lung Adenocarcinoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Lung Adenocarcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Lung Adenocarcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Lung Adenocarcinoma pipeline landscape. The...

April 2021 100 pages

Lung Disease (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Lung Disease (Respiratory) - Drugs in Development, 2021 SUMMARY Lung Disease (Respiratory) - Drugs in Development, 2021 provides an overview of the Lung Disease pipeline landscape. The report provides...

April 2021 85 pages

Lung Infections (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Lung Infections (Respiratory) - Drugs in Development, 2021 SUMMARY Lung Infections (Respiratory) - Drugs in Development, 2021 provides an overview of the Lung Infections pipeline landscape. The report...

April 2021 45 pages

Lung Injury (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Lung Injury (Respiratory) - Drugs in Development, 2021 SUMMARY Lung Injury (Respiratory) - Drugs in Development, 2021 provides an overview of the Lung Injury pipeline landscape. The report provides co...

April 2021 50 pages

Lupus Erythematosus (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Lupus Erythematosus (Immunology) - Drugs in Development, 2021 SUMMARY Lupus Erythematosus (Immunology) - Drugs in Development, 2021 provides an overview of the Lupus Erythematosus pipeline landscape....

April 2021 40 pages

Lupus Nephritis (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Lupus Nephritis (Immunology) - Drugs in Development, 2021 SUMMARY Lupus Nephritis (Immunology) - Drugs in Development, 2021 provides an overview of the Lupus Nephritis pipeline landscape. The report p...

April 2021 90 pages

Lymphangioleiomyomatosis (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Lymphangioleiomyomatosis (Respiratory) - Drugs in Development, 2021 SUMMARY Lymphangioleiomyomatosis (Respiratory) - Drugs in Development, 2021 provides an overview of the Lymphangioleiomyomatosis pip...

April 2021 30 pages

Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Lymphoblastic Lymphoma pipeline landsc...

April 2021 40 pages

Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Drugs in Development, 2021

US$ 3,000.00

Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Drugs in Development, 2021 SUMMARY Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Drugs in Development, 202...

April 2021 85 pages

Lymphoproliferative Disorders (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Lymphoproliferative Disorders (Oncology) - Drugs in Development, 2021 SUMMARY Lymphoproliferative Disorders (Oncology) - Drugs in Development, 2021 provides an overview of the Lymphoproliferative Diso...

April 2021 35 pages

Lymphotoxin Alpha (TNF Beta or Tumor Necrosis Factor Ligand Superfamily Member 1 or LTA) - Drugs in Development, 2021

US$ 3,000.00

Lymphotoxin Alpha (TNF Beta or Tumor Necrosis Factor Ligand Superfamily Member 1 or LTA) - Drugs in Development, 2021 SUMMARY Lymphotoxin Alpha (TNF Beta or Tumor Necrosis Factor Ligand Superfamily Me...

April 2021 40 pages

Lysosomal Storage Disorder (Metabolic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Lysosomal Storage Disorder (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Lysosomal Storage Disorder (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Lysosoma...

April 2021 60 pages

Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Macrophage Stimulating Protein Receptor...

April 2021 35 pages

Macular Degeneration (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 SUMMARY Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Macular Degeneration pipeline la...

April 2021 45 pages

Major Depressive Disorder (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Major Depressive Disorder (Central Nervous System) - Drugs in Development, 2021 SUMMARY Major Depressive Disorder (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Majo...

April 2021 170 pages

Major Prion Protein (ASCR or PrP27-30 or PrP33-35C or CD230 or PRNP) - Drugs in Development, 2021

US$ 3,000.00

Major Prion Protein (ASCR or PrP27-30 or PrP33-35C or CD230 or PRNP) - Drugs in Development, 2021 SUMMARY Major Prion Protein (ASCR or PrP27-30 or PrP33-35C or CD230 or PRNP) - Drugs in Development, 2...

April 2021 30 pages

Male Sexual Dysfunction (Male Health) - Drugs in Development, 2021

US$ 2,000.00

Male Sexual Dysfunction (Male Health) - Drugs in Development, 2021 SUMMARY Male Sexual Dysfunction (Male Health) - Drugs in Development, 2021 provides an overview of the Male Sexual Dysfunction pipeli...

April 2021 30 pages

Malignant Ascites (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Malignant Ascites (Oncology) - Drugs in Development, 2021 SUMMARY Malignant Ascites (Oncology) - Drugs in Development, 2021 provides an overview of the Malignant Ascites pipeline landscape. The report...

April 2021 30 pages

Malignant Fibrous Histiocytoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Malignant Fibrous Histiocytoma (Oncology) - Drugs in Development, 2021 SUMMARY Malignant Fibrous Histiocytoma (Oncology) - Drugs in Development, 2021 provides an overview of the Malignant Fibrous Hist...

April 2021 35 pages

Malignant Glioma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Malignant Glioma (Oncology) - Drugs in Development, 2021 SUMMARY Malignant Glioma (Oncology) - Drugs in Development, 2021 provides an overview of the Malignant Glioma pipeline landscape. The report pr...

April 2021 90 pages

Malignant Neoplasms (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Malignant Neoplasms (Oncology) - Drugs in Development, 2021 SUMMARY Malignant Neoplasms (Oncology) - Drugs in Development, 2021 provides an overview of the Malignant Neoplasms pipeline landscape. The...

April 2021 45 pages

Malignant Pleural Mesothelioma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Malignant Pleural Mesothelioma (Oncology) - Drugs in Development, 2021 SUMMARY Malignant Pleural Mesothelioma (Oncology) - Drugs in Development, 2021 provides an overview of the Malignant Pleural Meso...

April 2021 145 pages

Mantle Cell Lymphoma (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Mantle Cell Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Mantle Cell Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Mantle Cell Lymphoma pipeline landscape. T...

April 2021 375 pages

Maple Syrup Urine Disease (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Maple Syrup Urine Disease (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Maple Syrup Urine Disease (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Maple Syrup Ur...

April 2021 30 pages

Marginal Zone B-cell Lymphoma (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Marginal Zone B-cell Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Marginal Zone B-cell Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Marginal Zone B-cell Lym...

April 2021 200 pages

Mast Cell Leukemia (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Mast Cell Leukemia (Oncology) - Drugs in Development, 2021 SUMMARY Mast Cell Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the Mast Cell Leukemia pipeline landscape. The rep...

April 2021 30 pages

Mast/Stem Cell Growth Factor Receptor Kit (Proto Oncogene c Kit or Tyrosine Protein Kinase Kit or v Kit Hardy Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog or Piebald Trait Protein or CD117 or KIT or EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

Mast/Stem Cell Growth Factor Receptor Kit (Proto Oncogene c Kit or Tyrosine Protein Kinase Kit or v Kit Hardy Zuckerman 4 Feline Sarcoma Viral Oncogene Homolog or Piebald Trait Protein or CD117 or KIT...

April 2021 110 pages

Matrix Metalloproteinase (MMP or EC 3.4.24.) - Drugs in Development, 2021

US$ 3,000.00

Matrix Metalloproteinase (MMP or EC 3.4.24.) - Drugs in Development, 2021 SUMMARY Matrix Metalloproteinase (MMP or EC 3.4.24.) - Drugs in Development, 2021 provides in depth analysis on Matrix Metallo...

April 2021 35 pages

Medullary Thyroid Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Medullary Thyroid Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Medullary Thyroid Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Medullary Thyroid Cancer pipeline...

April 2021 85 pages

Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer/Testis Antigen 1.3 or MAGE3 Antigen or MAGEA3) - Drugs in Development, 2021

US$ 3,000.00

Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer/Testis Antigen 1.3 or MAGE3 Antigen or MAGEA3) - Drugs in Development, 2021 SUMMARY Melanoma Associated Antigen 3 (Antigen MZ2D or Cancer/Testis A...

April 2021 35 pages

MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) (Central Nervous System) - Drugs in Development, 2021 SUMMARY MELAS Syndrome (Mitochondrial Encephalomyopathy...

April 2021 35 pages

Melatonin Receptor Type 1A (MT1 or MTNR1A) - Drugs in Development, 2021

US$ 3,000.00

Melatonin Receptor Type 1A (MT1 or MTNR1A) - Drugs in Development, 2021 SUMMARY Melatonin Receptor Type 1A (MT1 or MTNR1A) - Drugs in Development, 2021 provides in depth analysis on Melatonin Receptor...

April 2021 35 pages

Melatonin Receptor Type 1B (MT2 or MTNR1B) - Drugs in Development, 2021

US$ 3,000.00

Melatonin Receptor Type 1B (MT2 or MTNR1B) - Drugs in Development, 2021 SUMMARY Melatonin Receptor Type 1B (MT2 or MTNR1B) - Drugs in Development, 2021 provides in depth analysis on Melatonin Receptor...

April 2021 35 pages

Membrane Associated Progesterone Receptor Component 1 (Sigma 2 Receptor or PGRMC1) - Drugs in Development, 2021

US$ 3,000.00

Membrane Associated Progesterone Receptor Component 1 (Sigma 2 Receptor or PGRMC1) - Drugs in Development, 2021 SUMMARY Membrane Associated Progesterone Receptor Component 1 (Sigma 2 Receptor or PGRMC...

April 2021 40 pages

Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021

US$ 2,000.00

Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 SUMMARY Membranoproliferative Glomerulonephritis Type II...

April 2021 35 pages

Membranous Glomerulonephritis (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021

US$ 2,000.00

Membranous Glomerulonephritis (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 SUMMARY Membranous Glomerulonephritis (Genito Urinary System And Sex Hormones) - Drugs in Developmen...

April 2021 35 pages

Memory Impairment (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Memory Impairment (Central Nervous System) - Drugs in Development, 2021 SUMMARY Memory Impairment (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Memory Impairment pi...

April 2021 35 pages

Meningioma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Meningioma (Oncology) - Drugs in Development, 2021 SUMMARY Meningioma (Oncology) - Drugs in Development, 2021 provides an overview of the Meningioma pipeline landscape. The report provides comprehensi...

April 2021 55 pages

Menopausal Disorders (Women's Health) - Drugs in Development, 2021

US$ 2,000.00

Menopausal Disorders (Women's Health) - Drugs in Development, 2021 SUMMARY Menopausal Disorders (Women's Health) - Drugs in Development, 2021 provides an overview of the Menopausal Disorders pipeline...

April 2021 30 pages

Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Drugs in Development, 2021

US$ 3,000.00

Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Drugs in Development, 2021 SUMMARY Mesothelin (CAK1 Antigen or Pre Pro Megakaryocyte Potentiating Factor or MSLN) - Dru...

April 2021 35 pages

Metabolic Syndrome (Metabolic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Metabolic Syndrome (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Metabolic Syndrome (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Metabolic Syndrome pipel...

April 2021 60 pages

Filters

Clear all